Financial reports
10-K
2023 FY
Annual report
21 Feb 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
10-K
2022 FY
Annual report
13 Feb 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
2 Aug 22
10-Q
2022 Q1
Quarterly report
4 May 22
10-K
2021 FY
Annual report
23 Feb 22
10-Q
2021 Q3
Quarterly report
4 Nov 21
Current reports
8-K
Outset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of Directors
13 Mar 24
8-K
Outset Medical Reports Fourth Quarter and Full Year 2023 Financial Results
21 Feb 24
8-K
Outset Medical Reports Unaudited Fourth Quarter and 2023 Revenue, Provides 2024 Revenue and non-GAAP Gross Margin Guidance
8 Jan 24
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
2 Jan 24
8-K
Entry into a Material Definitive Agreement
11 Dec 23
8-K
Outset Medical Reports Third Quarter 2023 Financial Results
7 Nov 23
8-K
Outset Medical Reports Preliminary Third Quarter 2023 Financial Results
12 Oct 23
8-K
Outset Medical Reports Second Quarter 2023 Financial Results
2 Aug 23
8-K
Other Events
7 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
1 Jun 23
Registration and prospectus
S-8
Registration of securities for employees
21 Feb 24
S-8
Registration of securities for employees
13 Feb 23
S-8
Registration of securities for employees
23 Feb 22
424B4
Prospectus supplement with pricing info
9 Apr 21
S-1MEF
Registration of additional securities for an S-1
8 Apr 21
S-1
IPO registration
6 Apr 21
DRSLTR
Correspondence regarding draft registration statement
25 Mar 21
DRS
Draft registration statement
25 Mar 21
424B4
Prospectus supplement with pricing info
3 Dec 20
S-1
IPO registration
30 Nov 20
Proxies
DEFA14A
Additional proxy soliciting materials
11 Apr 24
DEF 14A
Definitive proxy
11 Apr 24
DEFA14A
Additional proxy soliciting materials
13 Apr 23
DEF 14A
Definitive proxy
13 Apr 23
DEFA14A
Additional proxy soliciting materials
25 Apr 22
DEFA14A
Additional proxy soliciting materials
14 Apr 22
DEF 14A
Definitive proxy
14 Apr 22
DEFA14A
Additional proxy soliciting materials
24 May 21
DEFA14A
Additional proxy soliciting materials
21 Apr 21
DEF 14A
Definitive proxy
21 Apr 21
Other
SD
Conflict minerals disclosure
31 May 23
EFFECT
Notice of effectiveness
9 Apr 21
CORRESP
Correspondence with SEC
6 Apr 21
CORRESP
Correspondence with SEC
6 Apr 21
UPLOAD
Letter from SEC
30 Mar 21
EFFECT
Notice of effectiveness
3 Dec 20
CORRESP
Correspondence with SEC
30 Nov 20
CORRESP
Correspondence with SEC
30 Nov 20
UPLOAD
Letter from SEC
23 Nov 20
EFFECT
Notice of effectiveness
16 Sep 20
Ownership
SC 13G/A
AMERIPRISE FINANCIAL INC
10 Apr 24
4
Marc Nash
15 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
4
BRENT D. LANG
13 Mar 24
3
BRENT D. LANG
13 Mar 24
4
Nabeel Ahmed
4 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
4
Nabeel Ahmed
26 Feb 24
4
Leslie Trigg
26 Feb 24
4
Steven S. Williamson
16 Feb 24